PPARA and neoplasm: In fact, the use of a compound derived from N-phenylsulfonyl (AA452), capable of blocking the activation of PPAR-α, has determined a strong effect on cell viability, reducing cell proliferation and migration and therefore decreasing tumor invasiveness [58].